EUCTR2018-001492-20-FI进行中（未招募）1 期
Pseudoxanthoma elasticum – supplementation therapy of pyrophosphate deficiency
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adults (>18 yrs) are included when they have a clinically proven PXE. We will use the data from our earlier registry study to select patients with either mild to severe retinal changes or signs of an occlusive vascular disease.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •Pregnancy, non-compliance or special groups according to researchers decision. Those without any signs of retinal or vascular disease are excluded. A fertile female without proper contraception.
研究者
相似试验
招募中
不适用
Pseudoxanthoma elasticum: a cohort study and design of a registry.PXEPseudoxanthoma elasticum100276641004706010003216NL-OMON52835niversitair Medisch Centrum Utrecht500
招募中
不适用
PPI Supplementation to Fight ECtopIc Calcification in PXEPseudoxanthoma ElasticumNCT04868578Centre Hospitalier Universitaire de Nice99
招募中
不适用
Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)Pseudoxanthoma ElasticumNCT06636344University Hospital, Angers650
Unknown
不适用
Characterization of Pseudoxanthoma ElasticumPseudoxanthoma ElasticumNCT02108392University Hospital, Bonn100
尚未招募
Unknown
Correlation of Xanthelasma with atherosclerosis, liver fat and fibrosisCTRI/2023/07/054847ational Diabetes Obesity and Cholesterol Foundation